This finding indicates that, besides the role of EGFR/HER3 and HER2/EGFR dimers [13], also HER2/HER3 dimers are major drivers of tumorigenesis in HER2low pancreatic cancer. This evidence concerns the gene ERBB3 and familial pancreatic carcinoma.